Clinical trial
Neurocognitive Effects of Opiate Agonist Treatment
NCT01733693 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurocognitive Effects of Opiate Agonist Treatment
- Lead sponsor
- Albert Einstein College of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- June 30, 2017
- Enrollment
- 135 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.